Home › with Excess of Blasts Refractory Anemia › Maryland
with Excess of Blasts Refractory Anemia clinical trials in Maryland
3 studies for with Excess of Blasts Refractory Anemia are looking for participants at sites in Maryland.
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 6 to 70 · All sexes · Updated Oct 5, 2026 · NCT01861106Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 12 to 120 · All sexes · Updated Oct 5, 2026 · NCT06303193Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 4 to 80 · All sexes · Updated Sep 22, 2026 · NCT01174108From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.